DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Bellerophon Announces Agreement With FDA On Its Planned Pivotal Phase 3 Study For The Treatment Of Pulmonary Hypertension Associated With Pulmonary Fibrosis

Benzinga · 03/10/2020 12:34